Andera Partners BioDiscovery Fund VII

About Andera Partners BioDiscovery Fund VII

First close at €300M+, target >€500M

Investment Focus

Location / RegionFrance

Funding StageGrowth

Industry Focus

Biotech

Med Tech

Therapeutics

Investor Signals Profile

active

Sweet Spot

Growth-stage European company in life sciences or midcap

life sciences

mid-cap buyout

expansion capital

infrastructure

sponsorless

Bullish Signals

€5.3B AUM, 367 portfolio cosexternal

Acto V closed €1.1B, above hard capexternal

Tubulis acquired by Gilead, up to $5Bexternal

Agomab Nasdaq listing, $200M raisedexternal

Real Deals Best Multi-Strategy House 2026external

Active Spain expansion underwayexternal

JenaValve FDA approval, first-of-kind deviceexternal

Alveus $160M Series A co-ledexternal

Spiro Medical $67M Series A ledexternal

Exciva €51M Series B, Alzheimer'sexternal

15 internal promotions — team scalingexternal

PE Magazine Top 3 rankingexternal

Contrarian Signals

Large platform, less agile for small cosexternal

6 siloed strategies — complex fit assessmentexternal

French-language comms — Paris-centric cultureexternal

Founder Do's

Show strong sustainable growth trajectory

Seek long-term partnership mindset

Highlight international expansion potential

Fit into defined strategy: biotech, midcap, infra

Emphasise ESG credentials — active ESG programme

Founder Don'ts

Expect early-stage seed funding

Pitch outside defined sector strategies

Underestimate partnership culture fit

Key GPs & Partners

Bruno Angles

Strategic Advisor

strategicsenior advisorinstitutional

Joaquín Gonzalo

Senior Advisor (Spain)

operatorSpain-focusedsponsorless

Vincent Bazzocchi

Partner (MidCap)

promotedmidcapoperator

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size€300M

Saves0

Website

Key People

Sofia Ioannidou, Gilles Nobécourt, Olivier Litzka, Raphaël Wisniewski, Jan Van den Bossche

Bruno AnglesStrategic Advisor

Joaquín GonzaloSenior Advisor (Spain)

Vincent BazzocchiPartner (MidCap)